Research projects granted in 2025

2504 – Dr. C. Voermans/Prof M. Hazenberg/Dr. B. Blom: At the barriers: innate lymphoid cells to protect against graft versus host disease.                   

Budget: € 450.000, Project duration: 3 years

2513 – Dr. R. Kapur/Dr. R. Nieuwland: Understanding the contribution of platelet extracellular vesicles to the bleeding risk and response to therapy in chronic immune thrombocytopenia.

Budget: € 442.650, Project duration: 4 years

2519 – Dr. C. Robin: Unveiling the hematopoietic stem cell power of gastruloids.

Budget: € 449.758, Project duration: 3 years

2523 – Prof N.P. Juffermans: Understanding red blood cell clearance during anemia of inflammation.

Budget: € 449.705, Project duration: 4 years

2525 – Dr. J.M.I. Vos/Dr. R. Pouw: Unravelling pathological mechanisms in autoimmune hemolytic anemia.

Budget: € 450.000, Project duration: 4 years

2534 – Dr. D. Amsen: Exploiting unique T Cell Receptor signalling properties for selective modulation of Regulatory T cells.

Budget: € 450.000, Project duration: 3 years

Anniversary Grant

AG-2505 – Dr. M. van den Biggelaar et al.:

HEMOTWIN-BD: Dissecting Proteoforms in Bleeding Disorders

Budget: € 1.600.000, Project duration: 4 years

ECG-2502 - Dr. Lisa Dovern (Amsterdam UMC – VUmc): Exploring Immune Reconstitution, Phenotype, and Function of Peripheral Blood Mononuclear Cells before and after Haploidentical Stem Cell Transplantation in Patients with Sickle Cell Disease

Budget: € 198.000, Project duration: 2 years

ECG-2504 – Dr. Minka Zivkovic (UMCU): A Bispecific Single Domain Antibody Strategy to Restore the FVIII-VWF Complex in Type 2N Von Willebrand Disease

Budget: € 200.000, Project duration: 2 years

ECG-2508 - Dr. Sophie Bernelot Moens (Amsterdam UMC - VUmc): Elucidating aberrant B celI signaling in auto immune hemolytic anemias; understanding disease heterogeneity and treatment responses: A pilot study

Budget: € 25.000, Project duration: 1 year